Search Results - "Shin, Hyung Ju"
-
1
Detection of Circulating Tumor Cells in Human Peripheral Blood Using Surface-Enhanced Raman Scattering Nanoparticles
Published in Cancer research (Chicago, Ill.) (01-03-2011)“…The detection and characterization of circulating tumor cells (CTC) holds great promise for personalizing medicine and optimizing systemic therapy. However,…”
Get full text
Journal Article -
2
Drug-coated microneedles for rapid and painless local anesthesia
Published in Biomedical microdevices (01-03-2017)“…This study showed that drug-coated PLLA (Poly (L-lactide)) microneedle arrays can induce rapid and painless local anesthesia. Microneedle arrays were…”
Get full text
Journal Article -
3
Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice
Published in PloS one (18-06-2015)“…Influenza is one of the critical infectious diseases globally and vaccination has been considered as the best way to prevent. In this study, immunogenicity and…”
Get full text
Journal Article -
4
Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis
Published in PloS one (25-02-2014)“…Resistance to chemotherapy remains a major obstacle in cancer therapy. This study aimed to evaluate the molecular mechanism and efficacy of honokiol in…”
Get full text
Journal Article -
5
Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies
Published in Clinical cancer research (01-03-2013)“…We investigated the efficacy and underlying molecular mechanism of a novel chemopreventive strategy combining EGF receptor (EGFR) tyrosine kinase inhibitor…”
Get full text
Journal Article -
6
Tumor Growth Inhibition by Simultaneously Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 in a Xenograft Model
Published in Clinical cancer research (01-09-2005)“…Purpose: Our previous study revealed that simultaneously targeting epidermal growth factor receptor (EGFR) tyrosine kinase and cyclooxygenase-2 (COX-2)…”
Get full text
Journal Article -
7
Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer
Published in Clinical cancer research (01-05-2001)“…C225, a human-mouse chimerized monoclonal antibody directed against the epidermal growth factor receptor (EGFr), has a synergistic effect with cisplatin in…”
Get full text
Journal Article -
8
Interaction between epidermal growth factor receptor– and cyclooxygenase 2–mediated pathways and its implications for the chemoprevention of head and neck cancer
Published in Molecular cancer therapeutics (01-09-2005)“…Head and neck squamous cell carcinoma is a well-known model for chemoprevention studies because of its field cancerization effect, its multistep carcinogenesis…”
Get full text
Journal Article -
9
Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice
Published in Cancer chemotherapy and pharmacology (01-03-2012)“…Purpose DT-IgG is a fully humanized dual-target therapeutic antibody being developed to simultaneously target epidermal growth factor receptor (EGFR) and…”
Get full text
Journal Article -
10
HFT-T, a Targeting Nanoparticle, Enhances Specific Delivery of Paclitaxel to Folate Receptor-Positive Tumors
Published in ACS nano (27-10-2009)“…Nonspecific distribution of chemotherapeutic drugs (such as paclitaxel) is a major factor contributing to side effects and poor clinical outcomes in the…”
Get full text
Journal Article -
11
Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery
Published in Expert opinion on drug delivery (02-01-2016)“…The skin, as the largest organ, is a better option for drug delivery in many diseases. However, most transdermal delivery is difficult due to the low…”
Get more information
Journal Article -
12
Phase I Clinical and Pharmacodynamic Evaluation of Oral CI-1033 in Patients with Refractory Cancer
Published in Clinical cancer research (15-05-2007)“…Purpose: To determine the tolerability and pharmacokinetics of CI-1033 given daily for 7 days of a 21-day cycle. Tumor response and changes in erbB receptor…”
Get full text
Journal Article -
13
Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53
Published in The Journal of biological chemistry (05-11-2010)“…Natural dietary agents have drawn a great deal of attention toward cancer prevention because of their wide safety margin. However, single agent intervention…”
Get full text
Journal Article -
14
Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine
Published in Journal of controlled release (10-11-2017)“…Microneedles are the micrometer size devices used for the delivery of vaccines and biotherapeutics. In order to increase the vaccine efficacy and reduce the…”
Get full text
Journal Article -
15
Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma
Published in Molecular cancer therapeutics (01-07-2014)“…The EGFR monoclonal antibody cetuximab is the only approved targeted agent for treating head and neck squamous cell carcinoma (HNSCC). Yet resistance to…”
Get full text
Journal Article -
16
C-di-GMP with influenza vaccine showed enhanced and shifted immune responses in microneedle vaccination in the skin
Published in Drug delivery and translational research (01-06-2020)“…A microneedle is a biomedical device which consists of multiple micron scale needles. It is widely used in various fields to deliver drugs and vaccines to the…”
Get full text
Journal Article -
17
Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma
Published in Cancer (25-08-2003)“…BACKGROUND Accurate diagnosis of malignant mesothelioma (MM) in effusion fluid specimens can be challenging. Previous cytogenetic studies demonstrated that…”
Get full text
Journal Article -
18
Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study
Published in Cancer prevention research (Philadelphia, Pa.) (01-03-2014)“…Epidermal growth factor receptor (EGFR) and COX-2 inhibitors synergistically inhibit head and neck squamous cell carcinoma tumorigenesis in preclinical…”
Get full text
Journal Article -
19
Endoscopic ultrasound-guided fine-needle aspiration in 179 cases: the M. D. Anderson Cancer Center experience
Published in Cancer (25-06-2002)“…Recently, endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) has emerged as a diagnostic adjunct for small pancreatic lesions and abdominal and…”
Get full text
Journal Article -
20
A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment
Published in International journal of cancer (15-08-2012)“…An antibody simultaneously targeting epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF), two major tumor growth‐driving…”
Get full text
Journal Article